Technical Analysis for PROF - Profound Medical Corp.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Earnings Movers | Other | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 1.21% | |
Stochastic Buy Signal | Bullish | 1.21% | |
Inside Day | Range Contraction | 1.21% | |
Gapped Up | Strength | 1.21% | |
Oversold Stochastic | Weakness | 1.21% | |
20 DMA Resistance | Bearish | 1.15% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 13 hours ago |
10 DMA Resistance | about 13 hours ago |
Possible NR7 | about 14 hours ago |
Possible Inside Day | about 14 hours ago |
60 Minute Opening Range Breakout | about 15 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
Profound Medical Corp. operates as a medical technology company focuses on magnetic resonance guided ablation procedures in Canada, Germany, and Finland. It is developing a treatment to ablate the prostate gland in prostate cancer patients, treatment of uterine fibroids and nerves, and palliative pain treatment for patients with metastatic bone disease. The company is headquartered in Mississauga, Canada.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Pain Bone Medical Technology Prostate Cancer Interventional Radiology Ablation Magnetic Resonance Nerve Bone Disease Radiofrequency Ablation Fibroids Neoplasms Uterine Fibroid Targeted Radiofrequency Ablation
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Pain Bone Medical Technology Prostate Cancer Interventional Radiology Ablation Magnetic Resonance Nerve Bone Disease Radiofrequency Ablation Fibroids Neoplasms Uterine Fibroid Targeted Radiofrequency Ablation
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 15.49 |
52 Week Low | 7.13 |
Average Volume | 32,108 |
200-Day Moving Average | 8.94 |
50-Day Moving Average | 8.15 |
20-Day Moving Average | 7.72 |
10-Day Moving Average | 7.57 |
Average True Range | 0.37 |
RSI (14) | 40.12 |
ADX | 17.66 |
+DI | 16.85 |
-DI | 20.03 |
Chandelier Exit (Long, 3 ATRs) | 7.36 |
Chandelier Exit (Short, 3 ATRs) | 8.40 |
Upper Bollinger Bands | 8.24 |
Lower Bollinger Band | 7.20 |
Percent B (%b) | 0.29 |
BandWidth | 13.51 |
MACD Line | -0.21 |
MACD Signal Line | -0.19 |
MACD Histogram | -0.0177 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 7.85 | ||||
Resistance 3 (R3) | 7.86 | 7.75 | 7.79 | ||
Resistance 2 (R2) | 7.75 | 7.67 | 7.75 | 7.77 | |
Resistance 1 (R1) | 7.63 | 7.61 | 7.58 | 7.62 | 7.75 |
Pivot Point | 7.52 | 7.52 | 7.50 | 7.52 | 7.52 |
Support 1 (S1) | 7.40 | 7.44 | 7.35 | 7.39 | 7.25 |
Support 2 (S2) | 7.29 | 7.38 | 7.29 | 7.23 | |
Support 3 (S3) | 7.17 | 7.29 | 7.21 | ||
Support 4 (S4) | 7.16 |